Division of Clinical Pharmacology

DNA sequence
January 5, 2016

Vanderbilt study raises questions about reporting incidental genetic findings

A genetic test that suggests a patient may be at increased risk for potentially fatal heart rhythms is very often not as ominous as it sounds.

By Bill Snyder
December 13, 2015

Personalized medicine is topic of new Vanderbilt massive open online course

Enrollment has opened for Case Studies in Personalized Medicine, Vanderbilt’s latest free massive open online course, or MOOC. The six-week course starts Jan. 15.

By Paul Govern
genetic sequence
September 10, 2015

Grants spur effort to add genetic data to EMR

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records.

By Bill Snyder
July 9, 2015

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

By Bill Snyder
May 7, 2015

Task force named to prioritize Academic Strategic Plan health initiatives

A new faculty task force has been appointed to prioritize and refine the eight health-related initiatives in the Academic Strategic Plan and to inventory existing health-related interdisciplinary centers and institutes at Vanderbilt.

By VUMC News and Communications
April 2, 2015

Pharmacogenomics expert set for Wilkinson Lecture

Mary Relling, Pharm.D., chair of the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology on Thursday, April 9.

By Bill Snyder
February 19, 2015

Workshop explores President’s Precision Medicine Initiative

The Precision Medicine Initiative is a national effort announced by President Obama during his State of the Union address to provide more effective treatment and prevention strategies for individuals by taking into account their unique genetic, environmental and lifestyle factors.
By Bill Snyder
February 12, 2015

VU study explores inflammation, hypertension link

The evidence is increasing: the immune system and inflammation are key contributors to high blood pressure.
By Bill Snyder
January 13, 2015

Cognitive changes in ‘standing’ syndrome

Patients with orthostatic intolerance – problems when standing – have cognitive changes, even when seated, compared to healthy individuals.
By VUMC News and Communications
January 9, 2015

Does fish oil help prevent A-fib?

Growing evidence suggests that fish oil, thought to directly prevent inflammation, oxidative stress and heart disease, may have limited clinical utility.
By VUMC News and Communications
November 13, 2014

Speaker explores promise of ‘bioelectronic medicine’

Can an implanted electrical device like a cardiac pacemaker effectively treat inflammatory diseases like rheumatoid arthritis, including cases that have not responded to drug therapy?
By Bill Snyder
November 7, 2014

Overactive stress response in obesity

An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial.
By VUMC News and Communications
October 24, 2014

Immune cells’ role in hypertension

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.
By Leigh MacMillan
1 … 6 7 8 9 10 11